Reference Source

Deltas Pharma( Padmavati ) · 99-39 · INDIA

For Deltas Pharma( Padmavati ) · 99-39 · INDIA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is INDIA; product is Deltas Pancha Tulasi Drops Basils - 5 | Deltas Pancha Tulasi Drops Basils - 5; product code is 28 C - - 04 Basil (Sweet Basil), Natural Extract or Flavor (Spice) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 06/22/2017; address is Old Industrial Area , Haridwar, INDIA, verified against its source on 2026-09-16.

Firm
Deltas Pharma( Padmavati ) verified
Import alert
99-39
Import alert name
Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
Country
INDIA verified
Address
Old Industrial Area , Haridwar, INDIA verified
Date published
06/22/2017 verified
Product code
28 C - - 04 Basil (Sweet Basil), Natural Extract or Flavor (Spice) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. each item verified
Product
Deltas Pancha Tulasi Drops Basils - 5 | Deltas Pancha Tulasi Drops Basils - 5 each item verified
FDA notes
Section 403(y) of the Act in that the product label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The address must include a street address or the label must bear a domestic phone number. Section 403(s)(2)(C) of the Act in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling does not comply with 21CFR 101.36. Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. Additionally, the net contents should be located in the bottom 30% of the principal display panel. Section 403(i)(2) of the Act in that the product label fails to declare the common or usual names of each ingredient, as required by 21 CFR 101.36 and 21 CFR 101.4. Label declares "solubiliser" along with other dietary ingredients, but this is not the common or usual name for an ingredient. | Section 403(y) of the Act in that the product label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The address must include a street address or the label must bear a domestic phone number. Section 403(s)(2)(C) of the Act in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling does not comply with 21CFR 101.36. Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. Additionally, the net contents should be located in the bottom 30% of the principal display panel. Section 403(i)(2) of the Act in that the product label fails to declare the common or usual names of each ingredient, as required by 21 CFR 101.36 and 21 CFR 101.4. Label declares "solubiliser" along with other dietary ingredients, but this is not the common or usual name for an ingredient. each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Deltas Pharma( Padmavati ) Date Published : 06/22/2017 Old Industrial Area , Haridwar, INDIA 28 C - - 04 Basil (Sweet Basil), Natural Extract or Flavor (Spice) Date Published: 06/22/2017 Desc: Deltas Pancha Tulasi Drops Basils - 5 Notes: Section 403(y) of the Act in that the product label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The address must include a street address or the label must bear a domestic phone number. Section 403(s)(2)(C) of the Act in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling does not comply with 21CFR 101.36. Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. Additionally, the net contents should be located in the bottom 30% of the principal display panel. Section 403(i)(2) of the Act in that the product label fails to declare the common or usual names of each ingredient, as required by 21 CFR 101.36 and 21 CFR 101.4. Label declares "solubiliser" along with other dietary ingredients, but this is not the common or usual name for an ingredient. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/22/2017 Desc: Deltas Pancha Tulasi Drops Basils - 5 Notes: Section 403(y) of the Act in that the product label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The address must include a street address or the label must bear a domestic phone number. Section 403(s)(2)(C) of the Act in that the label fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling does not comply with 21CFR 101.36. Section 403(e)(2) of the Act because the label fails to declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. Additionally, the net contents should be located in the bottom 30% of the principal display panel. Section 403(i)(2) of the Act in that the product label fails to declare the common or usual names of each ingredient, as required by 21 CFR 101.36 and 21 CFR 101.4. Label declares "solubiliser" along with other dietary ingredients, but this is not the common or usual name for an ingredient.

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.